Zilico Receives CE Mark for ZedScan I Cervical Cancer Detection Device

Medgadget previously reported on Zilico’s device for cancer detection in 2009 as a multi-centre clinical trial was underway. While the device might have changed names from APX to Zedscan, Zilico has received the CE Mark approval for its commercial ...

Source: Medgadget - October 7, 2013 Category: Technology Consultants Authors: Nishey Wanchoo Tags: Ob/Gyn Oncology Source Type: blogs